Hematology

Hypertension Management in Cancer Patients

Conditions:   Blood Pressure;   Hypertension;   Cancer;   Cancer, Breast;   Cancer of Prostate;   CLL;   Hematopoietic Malignancy
Intervention:   Other: Automated Messaging
Sponsors:   Duke University;   Duke Institute for Health Innovation
Not yet recruiting
ClinicalTrials.gov: Hematology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 19, 2019 / by / in
Cell-based Assays for Antibody-mediated Transplant Rejection

Condition:   Antibody-Mediated Graft Rejection
Intervention:   Diagnostic Test: Alloantigen-specific B-cells
Sponsors:   Plexision;   Medical University of South Carolina;   Erie County Medical Center, Buffalo, NY;   CSL Behring, King of Prussia, Pennsylvania
Recruiting
ClinicalTrials.gov: Hematology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 18, 2019 / by / in
A Phase 1 Study of Engineered Donor Grafts (OrcaGraft) in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Conditions:   Acute Myeloid Leukemia;   Acute Lymphoblastic Leukemia;   Myelodysplastic Syndromes;   Acute Leukemia
Intervention:   Biological: OrcaGraft
Sponsor:   Orca Biosystems, Inc.
Recruiting
ClinicalTrials.gov: Hematology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 17, 2019 / by / in
Trial to Assess the Bioavailability of Quetiapine Versus Seroquel® in Subjects With Schizophrenia or Bipolar Disorder

Conditions:   Bipolar Disorder;   Schizophrenia
Interventions:   Drug: Seroquel IR 300mg;   Drug: Seroquel IR 25mg;   Drug: Quetiapine Formulation A 300mg;   Drug: Quetiapine Formulation B 300mg;   Drug: Quetiapine Formulation 25mg
Sponsors:   Otsuka Pharmaceutical Development & Commercialization, Inc.;   PRA Health Sciences
Recruiting
ClinicalTrials.gov: Hematology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 14, 2019 / by / in
Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide

Condition:   Chronic Granulomatous Disease
Interventions:   Drug: Busulfan;   Drug: Alemtuzumab;   Drug: Cyclophosphamide;   Drug: Sirolimus;   Radiation: Total Body Irradiation;   Biological: Allogeneic peripheral blood stem cell
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting
ClinicalTrials.gov: Hematology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 11, 2019 / by / in
The NUTRIENT Trial (NUTRitional Intervention Among myEloproliferative Neoplasms): Feasibility Phase

Conditions:   Myeloproliferative Disorder;   Myeloproliferative Syndrome;   Myelofibrosis;   Polycythemia Vera;   Essential Thrombocythemia
Interventions:   Other: USDA Diet;   Other: Mediterranean Diet
Sponsor:   University of California, Irvine
Recruiting
ClinicalTrials.gov: Hematology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 10, 2019 / by / in